Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Register
Register
Register

Project cooperationUpdated on 23 July 2026

Medical systems aimed at increasing the efficacy of chemotherapy

Founder at Hlectron

Athens, Greece

About

Hlectron is developing two medical systems aimed at increasing the efficacy of chemotherapy. Our first generation system is based on a non invasive protocol and is monstrated to increase survival rates of breast cancer patients by 15%.

Our second generation is invasive and animal trials have demonstrated an increase in survival rates of 40% without administering any chemotherapy to the animals.

The technology is based on magnetic nano complexes and electromagnetic fields that increase the concentration and lifetime of free radicals.

Topic

  • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
  • Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities